EcoDrugPlus

Platelet-Derived Growth Factor Beta Polypeptide B

Ensembl ID : ENSIPUG00000002192
Gene Symbol: PDGFBB
3 Cross references
196 Possible Orthologues:

Platelet-Derived Growth Factor Receptor, Alpha Polypeptide

Ensembl ID : ENSIPUG00000010113
Gene Symbol: PDGFRA
3 Cross references
204 Possible Orthologues:

Platelet-Derived Growth Factor Receptor, Beta Polypeptide

Ensembl ID : ENSIPUG00000009456
Gene Symbol: PDGFRB
3 Cross references
198 Possible Orthologues:

Polo-Like Kinase 4 (Drosophila)

Ensembl ID : ENSIPUG00000023926
Gene Symbol: PLK4
3 Cross references
215 Possible Orthologues:

Poly (Adp-Ribose) Polymerase 1

Ensembl ID : ENSIPUG00000020250
Gene Symbol: PARP1
3 Cross references
209 Possible Orthologues:

Poly (Adp-Ribose) Polymerase 2

Ensembl ID : ENSIPUG00000015405
Gene Symbol: PARP2
3 Cross references
185 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 3

Ensembl ID : ENSIPUG00000018781
Gene Symbol: PARP3
3 Cross references
199 Possible Orthologues:

Polyunsaturated Fatty Acid Lipoxygenase Alox12

Ensembl ID : ENSIPUG00000004748
Gene Symbol: LOC108267744
4 Cross references
195 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSIPUG00000002165
Gene Symbol: PORCN
4 Cross references
193 Possible Orthologues:

Porcupine O-Acyltransferase Like

Ensembl ID : ENSIPUG00000000359
Gene Symbol: PORCNL
4 Cross references
197 Possible Orthologues:

Potassium Channel, Subfamily K, Member 2b

Ensembl ID : ENSIPUG00000010928
Gene Symbol: KCNK2B
3 Cross references
213 Possible Orthologues:

Potassium Channel, Subfamily K, Member 9

Ensembl ID : ENSIPUG00000005285
Gene Symbol: KCNK9
3 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).